Ramasubramanian Baalachandran

Ramasubramanian Baalachandran practices at Central Vermont Medical Center - Berlin HOPD (130 Fisher Rd, Mob-C) in Berlin, Vermont.

Ramasubramanian Baalachandran's NPI, 1386085033, was assigned on July 10, 2013. Ramasubramanian Baalachandran holds Vermont license 042-0014392.

Ramasubramanian Baalachandran's primary practice is Central Vermont Medical Center - Berlin HOPD (130 Fisher Rd, Mob-C), at 130 Fisher Rd, Mob-C, Berlin, VT 05602.

Ramasubramanian Baalachandran's primary practice is Central Vermont Medical Center - Berlin HOPD (130 Fisher Rd, Mob-C) in Berlin, Vermont. Ramasubramanian Baalachandran is also affiliated with Central Vermont Medical Center. The medical group on file is University of Vermont Medical Center. Dmand AI also links Ramasubramanian Baalachandran to 4 more hospitals and 1 medical group, each named with a free account. Ramasubramanian Baalachandran's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Ramasubramanian Baalachandran practices, 6 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Ramasubramanian Baalachandran's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Ramasubramanian Baalachandran is licensed in Vermont.

CMS data shows 817 Medicare services from Ramasubramanian Baalachandran across 14 procedure codes in 2024, for 451 Medicare patients. Medicare paid $47,966 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 451 Medicare patients who saw Ramasubramanian Baalachandran in 2024. The largest group is 65 to 74, with 190 patients. 71% of them have high blood pressure, and 65% have high cholesterol. 27% are also on Medicaid. Their average risk score is 1.79, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Ramasubramanian Baalachandran's median patient age at 71, with 54% women.

In 2024, Ramasubramanian Baalachandran wrote 927 Medicare Part D claims for 172 patients. 33% of them were for generic drugs. CMS names the drug for 804 of them, across 24 drugs with 11 or more claims each, at $644,105 in total drug cost. In 2023, CMS named 872 claims across 26 drugs.

Ramasubramanian Baalachandran accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Ramasubramanian Baalachandran as offering telehealth.

Dmand AI links 5 papers to Ramasubramanian Baalachandran in 2022. Ramasubramanian Baalachandran's most frequent co-authors are Sunil Rajan, MD, Cameron D. Hypes, MD and Stephanie Lee Labedz, MD.